Leading Cancer Researcher: They’re Ignoring My Research, Cancer Patients Must Know This!

What It Covers

Professor Thomas Seyfried, cancer researcher at Boston College, presents his metabolic theory of cancer — that mitochondrial damage, not genetic mutation, drives tumor growth. He argues that restricting glucose and glutamine while elevating ketones through diet, fasting, and repurposed drugs can manage even terminal cancers far more effectively than conventional chemotherapy alone, with 626,000 Americans projected to die from cancer in 2026.

Key Questions Answered

• •Mitochondrial Origin of Cancer: Cancer is not primarily a genetic disease but a mitochondrial metabolic disorder. When mitochondria sustain chronic damage from carcinogens, inflammation, sleep apnea, stress, or processed foods, cells revert to ancient fermentation pathways using glucose and glutamine as fuel. This triggers dysregulated cell division. Every cancer type examined under electron microscopy shows structural mitochondrial damage — missing or deformed cristae — confirming damaged structure produces dysfunctional energy metabolism and uncontrolled growth.
• •Glucose-Ketone Index (GKI) as a Health Biomarker: The GKI, calculated by converting blood glucose to millimolar and dividing by blood ketone levels in millimolar, provides a single number reflecting mitochondrial health. A GKI below 12 places individuals in a prevention zone where chronic disease and cancer risk drops substantially. Devices like Keto-Mojo measure both values via finger prick. A GKI of 1–3 represents the therapeutic zone used alongside cancer treatment protocols in Istanbul and Greece.
• •Cancer's Two Fuel Dependencies: Tumor cells exclusively ferment glucose and glutamine for energy and cannot metabolize fatty acids or ketone bodies because their mitochondria are structurally broken. Healthy cells, by contrast, efficiently burn ketones. This metabolic asymmetry is the therapeutic target. Restricting dietary carbohydrates to lower glucose while simultaneously blocking glutamine metabolism using repurposed drugs like mebendazole starves tumor cells of both fuels simultaneously without harming normal tissue.
• •Ketosis Enhances Chemotherapy Efficacy at Lower Doses: Placing cancer patients in nutritional ketosis before and during chemotherapy allows significantly reduced drug doses while producing greater tumor kill. Ketosis removes the lactic acid and succinic acid shield that fermentation waste products create around tumor cells, making them vulnerable to treatment. Clinics in Istanbul currently apply this protocol to pancreatic and advanced breast cancers, achieving survival times of four to five years in cancers typically considered rapidly fatal.
• •Metastasis Driven by Macrophage-Tumor Hybrid Cells: Cancer spread occurs when immune macrophages fuse with stem-cell tumor cells, creating hybrid cells programmed to migrate throughout the body. These metastatic hybrids are primarily glutamine-driven. The Press-Pulse therapeutic strategy — developed by Seyfried, Dominic D'Agostino, and Joe Maroon — presses down glucose availability continuously while pulsing targeted glutamine-blocking agents to eliminate these mobile cells, potentially achieving disease resolution when combined with low-dose immunotherapy.
• •Lifestyle Factors That Damage Mitochondria: Chronic exposure to ultra-processed carbohydrates, physical inactivity, emotional stress, poor sleep, microplastics, forever chemicals (classified as Group 1 carcinogens by the IARC in 2023), synthetic pesticides (linked to a 41% increased lymphoma risk), and heavy metals in unfiltered water all reduce oxidative phosphorylation efficiency. Wolves in the wild rarely develop cancer; domestic dogs — sedentary, overfed, and confined — die from it as their leading cause of death, mirroring human patterns.
• •Prevention Zone Through Diet and Fasting: Transitioning from a high-carbohydrate diet to one emphasizing fatty fish, olive oil, avocado, and animal proteins — while eliminating ultra-processed carbohydrates — lowers GKI into the yellow-green prevention zone. A zero-carbohydrate dietary phase lasting approximately one week before water-only fasting significantly reduces the neurological difficulty of fasting by depleting glucose dependency first. Continuous glucose monitors worn temporarily help individuals map specific foods to blood sugar responses, building metabolic self-awareness before transitioning to periodic finger-prick monitoring.